Apcin-derived CDC20 inhibitors synergize with microtubule disruptors to induce mitotic catastrophe in acute leukemias
Andrea Marranci(Fondazione Pisa), G. Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Carla Boga(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Martina Ghetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Francesco Olimpico(Fondazione Pisa), Gabriele Micheletti(University of Bologna), Roberta Napolitano(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giovanni Martinelli(University of Bologna), Samantha Bruno(University of Bologna), Lorenzo Ledda(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori)
Cited by 0
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644